We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
(-2.3%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$29M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$14M |
| 3 |
Microsoft
MSFT
|
+$10.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.5M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.4M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.2M |
| 3 |
ExxonMobil
XOM
|
+$23.9M |
| 4 |
Warner Bros
WBD
|
+$15.4M |
| 5 |
RTX Corp
RTX
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.81% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.72% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Regeneron Pharmaceuticals
REGN
$72.9B
| $47.4M | 0.14% |
131,558
-4,946
| -4% | -$1.66M |
|
|
DFS
152
DELISTED
Discover Financial Services
DFS
| $47.4M | 0.14% |
736,211
-15,863
| -2% | -$994K |
|
153
Exelon
EXC
$48.1B
| $47.4M | 0.14% |
1,947,918
-23,793
| -1% | -$557K |
|
|
MRSH
154
Marsh
MRSH
$94.3B
| $47.3M | 0.14% |
903,952
-17,141
| -2% | -$894K |
|
155
Johnson Controls International
JCI
$85.1B
| $47.1M | 0.14% |
1,022,847
-11,231
| -1% | -$566K |
|
|
PXD
156
DELISTED
Pioneer Natural Resource Co.
PXD
| $47.1M | 0.14% |
239,060
-3,483
| -1% | -$737K |
|
157
Aflac
AFL
$65.5B
| $47M | 0.14% |
1,612,412
-129,648
| -7% | -$3.95M |
|
158
PPG Industries
PPG
$24.9B
| $46.8M | 0.14% |
475,930
-8,888
| -2% | -$906K |
|
159
Air Products & Chemicals
APD
$65.5B
| $46.1M | 0.14% |
382,699
-53,131
| -12% | -$6.49M |
|
160
Cognizant
CTSH
$26.5B
| $45.7M | 0.14% |
1,020,761
-13,911
| -1% | -$655K |
|
161
Cummins
CMI
$83.6B
| $45.1M | 0.14% |
341,771
-27,725
| -8% | -$4M |
|
|
PARA
162
DELISTED
Paramount Global Class B
PARA
| $44.9M | 0.13% |
839,345
-74,372
| -8% | -$4.38M |
|
|
SE
163
DELISTED
Spectra Energy Corp Wi
SE
| $44.8M | 0.13% |
1,140,817
-125,929
| -10% | -$5.19M |
|
164
Allstate
ALL
$70.6B
| $44M | 0.13% |
717,198
-19,935
| -3% | -$1.2M |
|
165
Devon Energy
DVN
$51.3B
| $43.9M | 0.13% |
644,295
-9,496
| -1% | -$706K |
|
|
HES
166
DELISTED
Hess
HES
| $43.5M | 0.13% |
461,689
-8,521
| -2% | -$843K |
|
167
Northrop Grumman
NOC
$76B
| $43M | 0.13% |
326,083
-8,438
| -3% | -$1.07M |
|
168
Franklin Resources
BEN
$16.8B
| $42.7M | 0.13% |
782,144
-67,851
| -8% | -$3.8M |
|
169
Kinder Morgan
KMI
$70.9B
| $42.6M | 0.13% |
1,111,578
+10,187
| +0.9% | +$387K |
|
|
CB
170
DELISTED
CHUBB CORPORATION
CB
| $42.4M | 0.13% |
466,066
-43,054
| -8% | -$3.92M |
|
171
Corning
GLW
$107B
| $42.2M | 0.13% |
2,181,439
-6,098
| -0.3% | -$127K |
|
172
American Electric Power
AEP
$70.4B
| $42.1M | 0.13% |
805,571
+21,695
| +3% | +$1.15M |
|
173
Truist Financial
TFC
$63.9B
| $41.5M | 0.12% |
1,116,362
-12,912
| -1% | -$488K |
|
|
MRO
174
DELISTED
Marathon Oil Corporation
MRO
| $41.5M | 0.12% |
1,102,856
-22,750
| -2% | -$902K |
|
175
Crown Castle
CCI
$34.6B
| $41.1M | 0.12% |
509,954
-13,706
| -3% | -$1.06M |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2014 Portfolio in Review
As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
- RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
- RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
- RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
- RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
- RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.